Literature DB >> 34592084

Decrease in Exacerbations During the Coronavirus Disease 2019 Pandemic in a Cohort of Veterans with COPD.

Christian Trujillo1, Brian Garnet2,3, Ali Vaeli Zadeh2, Gisel Urdaneta2, Michael Campos2,3.   

Abstract

BACKGROUND: Studies have shown a decline in hospitalizations due to acute exacerbations of COPD (AECOPD) during the coronavirus disease 2019 (COVID-19) pandemic. However, the impact of the pandemic in AECOPD of all severities in longitudinal cohorts of patients is lacking.
METHODS: We conducted analysis of 123 individuals with COPD who have been followed since 2017. AECOPDs of mild (treatment at home), moderate (emergency department or urgent visit evaluation), and severe (hospitalization) type were assessed by chart review and patient interview. Compliance with preventive measures to avoid COVID-19 infection was assessed in 2020. Differences between the rate of AECOPD by year was analyzed as well as differences in preventive measures by COPD disease severity.
RESULTS: During the COVID-19 pandemic in 2020, there was a significant reduction in AECOPDs in our cohort with 26 participants (21%) having an exacerbation compared to 46 (37%) in 2019, 52 (42%) in 2018, and 44 (36%) in 2017. Mean exacerbation rates decreased 54% overall and 74% in frequent exacerbators compared with the prior 3-year average. The decrease was noted in AECOPDs of all severities. Overall, there was a high rate of reported compliance with social distancing and face mask use that was significantly higher in the group with more severe COPD based on symptoms and forced expiratory volume in 1 second.
CONCLUSIONS: Individuals with COPD, including frequent exacerbators, showed a marked decrease in AECOPD during the COVID-19 pandemic and high adherence to recommended preventive measures. Evaluation of the impact of preventive strategies on AECOPD in a non-pandemic setting may be of value and requires further study. JCOPDF
© 2021.

Entities:  

Keywords:  COPD; COPD exacerbations; COVID-19

Year:  2021        PMID: 34592084      PMCID: PMC8686846          DOI: 10.15326/jcopdf.2021.0234

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  20 in total

1.  Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis.

Authors:  Golam Rabbani; Sheikh Mohammad Shariful Islam; Muhammad Aziz Rahman; Nuhu Amin; Bushra Marzan; Rishad Choudhury Robin; Sheikh M Alif
Journal:  Expert Rev Respir Med       Date:  2021-01-07       Impact factor: 3.772

Review 2.  Toward a consensus definition for COPD exacerbations.

Authors:  R Rodriguez-Roisin
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

3.  Disproportionate decline in admissions for exacerbated COPD during the COVID-19 pandemic.

Authors:  Thomas M Berghaus; Philipp Karschnia; Sabine Haberl; Martin Schwaiblmair
Journal:  Respir Med       Date:  2020-08-14       Impact factor: 3.415

4.  Viral Profile of COPD Exacerbations According to Patients.

Authors:  Dimopoulos G; Tsiodras S; Lerikou M; Aik Chranioti; Perros E; Anagnostopoulou U; Karakitsos P; Armaganidis A
Journal:  Open Respir Med J       Date:  2015-02-23

5.  Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy.

Authors:  Ovidio De Filippo; Fabrizio D'Ascenzo; Filippo Angelini; Pier Paolo Bocchino; Federico Conrotto; Andrea Saglietto; Gioel Gabrio Secco; Gianluca Campo; Guglielmo Gallone; Roberto Verardi; Luca Gaido; Mario Iannaccone; Marcello Galvani; Fabrizio Ugo; Umberto Barbero; Vincenzo Infantino; Luca Olivotti; Marco Mennuni; Sebastiano Gili; Fabio Infusino; Matteo Vercellino; Ottavio Zucchetti; Gianni Casella; Massimo Giammaria; Giacomo Boccuzzi; Paolo Tolomeo; Baldassarre Doronzo; Gaetano Senatore; Walter Grosso Marra; Andrea Rognoni; Daniela Trabattoni; Luca Franchin; Andrea Borin; Francesco Bruno; Alessandro Galluzzo; Alfonso Gambino; Annamaria Nicolino; Alessandra Truffa Giachet; Gennaro Sardella; Francesco Fedele; Silvia Monticone; Antonio Montefusco; Pierluigi Omedè; Mauro Pennone; Giuseppe Patti; Massimo Mancone; Gaetano M De Ferrari
Journal:  N Engl J Med       Date:  2020-04-28       Impact factor: 91.245

6.  Clinical Courses and Outcomes of Patients with Chronic Obstructive Pulmonary Disease During the COVID-19 Epidemic in Hubei, China.

Authors:  Weihua Hu; Minglin Dong; Mengqing Xiong; Dong Zhao; Yang Zhao; Mengmei Wang; Tao Wang; Zhenlian Liu; Li Lu; Ke Hu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-09-23

7.  COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis.

Authors:  Firoozeh V Gerayeli; Stephen Milne; Chung Cheung; Xuan Li; Cheng Wei Tony Yang; Anthony Tam; Lauren H Choi; Annie Bae; Don D Sin
Journal:  EClinicalMedicine       Date:  2021-03-18

8.  Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020.

Authors:  Sonja J Olsen; Eduardo Azziz-Baumgartner; Alicia P Budd; Lynnette Brammer; Sheena Sullivan; Rodrigo F Pineda; Cheryl Cohen; Alicia M Fry
Journal:  Am J Transplant       Date:  2020-12       Impact factor: 8.086

9.  Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective.

Authors:  Dominic L Sykes; Shoaib Faruqi; Luke Holdsworth; Michael G Crooks
Journal:  ERJ Open Res       Date:  2021-02-08

10.  Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic.

Authors:  King Pui Florence Chan; Ting Fung Ma; Wang Chun Kwok; Jackson Ka Chun Leung; Ka Yan Chiang; James Chung Man Ho; David Chi Leung Lam; Terence Chi Chun Tam; Mary Sau Man Ip; Pak Leung Ho
Journal:  Respir Med       Date:  2020-07-12       Impact factor: 4.582

View more
  3 in total

1.  Chronic disease relapses: A cross-sectional study of the associated factors and socioeconomic inequalities during the COVID-19 pandemic in Peru.

Authors:  Fabriccio J Visconti-Lopez; Akram Hernández-Vásquez; Dustin M Solorzano-Salazar; Diego Azañedo
Journal:  PLoS One       Date:  2022-09-16       Impact factor: 3.752

2.  Air quality in Mexico City during the COVID-19 lockdown possibly decreased COPD exacerbations.

Authors:  Francisco Montiel-Lopez; Daniela Rodríguez-Ramírez; Maricruz Cassou-Martínez; María Cristina Miranda-Márquez; Claudia González-González; Raúl H Sansores; María Eugenia Mayar-Maya; Rogelio Pérez-Padilla; Robinson Emmanuel Robles-Hernández; Ireri Thirion-Romero; Oliver Pérez-Bautista; Alejandra Ramírez-Venegas
Journal:  ERJ Open Res       Date:  2022-10-10

3.  Hospital admissions and mortality for acute exacerbations of COPD during the COVID-19 pandemic: A nationwide study in France.

Authors:  Jonas Poucineau; Tristan Delory; Nathanaël Lapidus; Gilles Hejblum; Christos Chouaïd; Sophie Le Cœur; Myriam Khlat
Journal:  Front Med (Lausanne)       Date:  2022-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.